← Pharmacists CPD
Incidence of Spina Bifida in Children; The Role of the Pharmacists
Please be informed that participation in the post-test assessment is mandatory for the issuance of certificates and the allocation of associated CPD points. Completion and passing of the post-test are required to validate your attendance and ensure compliance with CPD accreditation requirements. Thank you for your cooperation and commitment to professional development.
This CPD training event is a live, virtual Continuing Professional Development (CPD) session designed to equip practising pharmacists with up‑to‑date knowledge and practical skills for the prevention, early detection, and multidisciplinary management of spina bifida. A faculty of highly qualified clinicians, clinical pharmacists, public‑health specialists, and paediatric neurosurgeons will guide participants through the latest epidemiological trends, evidence‑based pharmacological interventions, and counselling strategies for families. The programme is fully interactive: short, focused presentations are interwoven with real‑world case studies, polling questions, and a moderated Q &A to ensure an engaging learning experience.
TARGET AUDIENCE – WHY PHARMACISTS?
Although spina bifida is a congenital condition, pharmacists occupy a pivotal position across the continuum of care—from antenatal folic‑acid advocacy and periconceptional supplementation, to postoperative medication optimisation and long‑term adherence support. Community, hospital, and public‑health pharmacists who routinely counsel women of child‑bearing age, manage paediatric prescriptions, or sit on medicines‑safety committees will find the content directly relevant to their daily practice. Participation will also satisfy mandatory CPD credits for licensure renewal.
WHY YOU SHOULD ATTEND
1. Gain concise, evidence‑based updates without leaving your workplace.
2. Interact in real time with a multidisciplinary expert panel and peers across the region.
3. Translate guideline recommendations into practical dispensing and counselling tips.
4. Strengthen your contribution to national birth‑defect prevention initiatives.
5. Earn accredited CPD hours recognised by the Pharmacy Council.
6. Receive post‑event resources—slide deck, reference list, and patient‑education leaflets—to reinforce learning.
We look forward to welcoming you to an informative and inspiring session that will sharpen your professional practice and enhance the lives of children living with spina bifida.
ORGANIZED BY
PROUDLY SPONSORED BY
This is a virtual event scheduled for Tuesday the 29th of April, 2025 at 17:00 GMT.
Moderator: Lady Pharm Esther Amoah, General Manager, HealthStar Company Limited,
Date: Tuesday, 29th April, 2025
Time: 17:00 GMT (5:00 PM Local Time)
AGENDA
1. Welcome and Introduction (5 minutes)
-
- Opening remarks and overview of session objectives.
2. Welcome remarks by LAPAG Chairperson
3. Remarks by the Chairman - PSGH President, Dr. Pharm Donkor
4. First Presentation
5. Second Presentation
6. Questions and Answers
7. Closing Remarks and Vote of Thanks with Closing Prayer
Overview
Course Description
This live, accredited CPD session equips practising pharmacists with the latest epidemiological insights on paediatric spina bifida, practical guidance on folic acid–based prevention, and evidence-driven pharmacotherapy for peri-operative and long-term care. Delivered by a multidisciplinary faculty, the programme blends concise presentations, real world case discussions, and interactive Q&A to foster actionable skills in counseling families, mitigating drug–nutrient interactions, and collaborating effectively within clinical teams—all aimed at improving outcomes and quality of life for affected children.
What you will learn
Participants will leave the session able to:
1. Outline current incidence trends and public health implications of spina bifida.
2. Emphasise folic acid supplementation and food fortification as key preventive measures.
3. Select and optimise pharmacotherapy for peri operative and long term management in affected children.
4. Recognise important drug–disease and drug–nutrient interactions.
5. Deliver effective, family centred counselling and education.
6. Work seamlessly within multidisciplinary teams to improve clinical and quality of life outcomes.
Course Content
Lecture Sessions
- LIVE EVENT: Tuesday, 29th April, 2025 from 1700 GMT (5:00 pm) 2 hours
Downloadables
No downloadable content added to this course yet.
Steps to Join Course
About Facilitators
- 3 Courses on CES
Pharm. Obedia Akweley Seaneke
BPharm., MSc, MSc, FGCPharm
Specialist Pharmacist in Pediatric Infectious Diseases and Head of Pharmacy of the Child Health
Korle-Bu Teaching Hospital, Accra, Ghana
Pharm. Obedia Akweley Seaneke is a Specialist Pharmacist in Pediatric Infectious Diseases at the Korle-Bu Teaching Hospital, Accra, Ghana. She is the Head of Pharmacy of the Child Health Department and is the Pharmacist in charge of the Asthma Clinic of the same institution.
View full profile / courses
- 1 Course on CES
Dr Anne Boakyewaa Anokye‑Kumatia
BPharm, PharmD, PhD Candidate, FGCPharm
Senior Specialist Paediatric Pharmacist || Lecturer
Komfo Anokye Teaching Hospital, KATH || Kwame Nkrumah University of Science and Technology, KNUST, Kumasi, Ghana
PharmDr Anne Boakyewaa Anokye‑Kumatia is a senior specialist paediatric pharmacist at Komfo Anokye Teaching Hospital, where she directs clinical pharmacy services for neonatal and paediatric wards and serves as the hospital’s principal resource on medication safety and therapeutics.
View full profile / coursesRelated Courses
